Takeda Pharmaceutical Company
PUBLIC
STATUS
45K-50K
EMPLOYEES
4502
STOCK SYMBOL
48
INVESTMENTS
$40.23
SHARE PRICE
(As of Friday Closing)
Description
Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 2.1 trillion in 2018. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. In future, management intends to focus future R&D and sales efforts on five areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue. Its geographic footprint will increase in the U.S. and diversify away from Japan, with pro-forma distribution expected to be about 48% U.S, 20% Japan, and 32% in the Rest of the World, or RoW.
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
- 1-1, Nihonbashi-Honcho 2-Chome
- Chuo-Ku
- Tokyo, 103-8668
- Japan
+81 00-0000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Takeda Pharmaceutical Company’s full profile, request a free trial.
Takeda Pharmaceutical Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $32.16 - $43.42 | $63.4B | $40.09 | -$0.24 | 4.4M | 1.58B |
Takeda Pharmaceutical Company Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
|---|---|---|---|---|
| Enterprise Value | 100,605,596 | 69,625,613 | 44,164,599 | 39,218,103 |
| Revenue | 26,142,026 | 18,915,530 | 15,971,882 | 15,985,469 |
| EBITDA | 5,009,154 | 3,687,828 | 3,663,284 | 2,956,237 |
| Net Income | 142,143 | 984,242 | 1,685,890 | 1,060,806 |
| Total Assets | 119,308,746 | 125,111,698 | 38,641,817 | 38,877,726 |
| Total Debt | 46,542,962 | 51,866,677 | 9,275,079 | 10,239,896 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Takeda Pharmaceutical Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical Company‘s full profile, request access.
Request full access to PitchBookTakeda Pharmaceutical Company Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hikma Pharmaceuticals | Corporation | London, United Kingdom | 0000 | 00000 | 000000000 | 00000 |
| 000 00000000000000 | Corporation | Mumbai, India | 00000 | 00000000000 | ||
| 00000000 | Corporate Backed or Acquired | Basel, Switzerland | 000000 | 000000000000 | ||
| 00000000 000000 | Corporate Backed or Acquired | Tokyo, Japan | 00000 | 000000000000 | ||
| 000000 | Corporation | New York, NY | 00000 | 000000 - 000 |
Takeda Pharmaceutical Company Investments & Acquisitions (48)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 00000000 | 19-Dec-2019 | 000000000 | 00000 | Drug Discovery | 00000000000 000000 00.0 |
| 0000 0000000000000 | 22-Oct-2019 | 000000000 00000 00 | Buildings and Property | ||
| 00000000 000000000 | 16-Oct-2019 | 00000 00000 00 | 00.000 | Biotechnology | |
| 0000000 0000000000 | 15-May-2019 | 00000 0000000 | Biotechnology | 00000000 000000 00 | |
| Shire | 08-Jan-2019 | Merger/Acquisition | 000.00 | Pharmaceuticals | 0000000000 00000 |
Takeda Pharmaceutical Company Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 00000000000 | 07-Dec-2017 | 000000000 00000000 | 00000 | Completed |
|
| 000000000 00000000 | 02-Aug-2017 | 0000 | 0000 | Completed |
|
| 000 000000 0000000 | 15-Feb-2017 | 00000 0000000 | Completed |
|
|
| 0000000 0000000000 | 14-Jun-2016 | 00000 00000 00 | 000.00 | Completed |
|
| Seattle Genetics | 17-Jan-2014 | PIPE | 000 | Completed |
Takeda Pharmaceutical Company Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Crescendo Biologics | Therapeutic Devices | Cambridge, United Kingdom | 2007 |
| 000000 00000000 | Corporate Venture Capital | Palo Alto, CA | 0000 |
| 0000000 | Biotechnology | Leuven, Belgium | 0000 |
| 000000 00000000 | Medical Supplies | Cambridge, MA | 0000 |
| 000000 (0000000) | Acquirer | Konstanz, Germany | 0000 |
Takeda Pharmaceutical Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical Company‘s full profile, request access.
Request full access to PitchBookTakeda Pharmaceutical Company Executive Team (35)
11 Former Executives
You’re viewing 5 of 35 executives. Get the full list »Takeda Pharmaceutical Company Board Members (15)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000000 00000 00.0 | Takeda Pharmaceutical Company | Board Member & President | 000 0000 | |
| 0000000000 00000 | Takeda Pharmaceutical Company | Chief Executive Officer & Board Member | 000 0000 | |
| 00000 00000000 | Takeda Pharmaceutical Company | Chief Financial Officer & Board Member | 000 0000 | |
| 00000 0000000 | Self | Board Member | 000 0000 | |
| 00000 0000 | Takeda Pharmaceutical Company | Outside Director | 000 0000 |
2 Former Board Members
You’re viewing 5 of 15 board members. Get the full list »